Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Whitehawk Therapeutics (WHWK) Shares Issued (2018 - 2025)

Historic Shares Issued for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q1 2025 value amounting to $100.0 million.

  • Whitehawk Therapeutics' Shares Issued changed N/A to $100.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $100.1 million, marking a year-over-year increase of 4800288.46%. This contributed to the annual value of $146000.0 for FY2024, which is 6421.57% down from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Shares Issued of $100.0 million as of Q1 2025.
  • Whitehawk Therapeutics' 5-year Shares Issued high stood at $155.0 million for Q3 2021, and its period low was -$70279.0 during Q2 2021.
  • In the last 5 years, Whitehawk Therapeutics' Shares Issued had a median value of $125000.0 in 2022 and averaged $27.3 million.
  • Its Shares Issued has fluctuated over the past 5 years, first surged by 29351.44% in 2022, then tumbled by 9672.13% in 2023.
  • Whitehawk Therapeutics' Shares Issued (Quarter) stood at $155.0 million in 2021, then tumbled by 53.47% to $72.1 million in 2022, then tumbled by 99.84% to $114000.0 in 2023, then tumbled by 54.39% to $52000.0 in 2024, then skyrocketed by 192211.54% to $100.0 million in 2025.
  • Its Shares Issued stands at $100.0 million for Q1 2025, versus $52000.0 for Q4 2024 and $94000.0 for Q2 2024.